Nevada SB 380: Revises provisions governing the reporting of data concerning the prices of prescription drugs. (BDR 40-445)

Status: Chapter 547. (as of 2021-06-11)

State: Nevada · Session: 81 · Bill: SB 380

Subjects: ASTHMA, DIABETES, FINES, HEALTH AND HUMAN SERVICES, DEPARTMENT OF, INSURANCE COMPANIES, MANUFACTURERS AND MANUFACTURING, PHARMACY BENEFIT MANAGERS, PRESCRIPTIONS

Sponsors: Senate Committee on Health and Human Services

View Nevada SB 380 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.